2025年第一次临时股东大会决议公告 证券代码：600568 证券简称：ST中珠 公告编号：2025-042号 中珠医疗控股股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025年9月15日 (二)股东大会召开的地点：珠海市情侣南路1号仁恒滨海中心5座8层 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 1、出席会议的股东和代理人人数2342、出席会议的股东所持有表决权的股份总数（股）536,965,5413、 出席会议的股东所持有表决权股份数占公司有表决权股份总数的比例（%）26.9443 (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，由董事长陈旭先生主持，会议采用现场投票和网络投票相结合的表决方式 进行表决。本次会议的召开和表决符合《公司法》、《上市公司股东会规则》、《上海证券交易所股票 上市规则》及《公司章程》等法律、法规及规范性文件的 ...

证券代码：600568 证券简称：ST中珠 公告编号：2025-042号 中珠医疗控股股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025年9月15日 (二)股东大会召开的地点：珠海市情侣南路1号仁恒滨海中心5座8层 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，由董事长陈旭先生主持，会议采用现场投票和网络投票相结合的表决方式 进行表决。本次会议的召开和表决符合《公司法》、《上市公司股东会规则》、《上海证券交易所股票 上市规则》及《公司章程》等法律、法规及规范性文件的规定，会议合法有效。 (五)公司董事、监事和董事会秘书的出席情况 1、公司在任董事9人，出席4人，董事戴绍宏先生、董事盛剑明先生、董事武有先生、独立董事尹显峰 女士、独立董事栗胜男女士因公 ...

北京德恒（深圳）律师事务所 关于中珠医疗控股股份有限公司 2025年第一次临时股东大会的 法律意见 北京德恒律师事务所 DeHeng Law Offices 深圳市福田区金田路 4018 号安联大厦 B 座 11 层 电话:0755-88286488 传真:0755-88286499 邮编:518026 北京德恒(深圳)律师事务所 关于中珠医疗控股股份有限公司 2025 年第一次临时股东大会的法律意见 北京德恒(深圳)律师事务所 关于中珠医疗控股股份有限公司 2025年第一次临时股东大会 的法律意见 德恒 06G20240426-03 号 致:中珠医疗控股股份有限公司 中珠医疗控股股份有限公司(以下简称"公司")2025 年第一次临时股东 大会(以下简称"本次会议")于2025年9月15日(星期一)召开。北京德恒 (深圳)律师事务所(以下简称"德恒"或"本所")受公司委托,指派邓宇戈 律师、李艾岭律师(以下简称"本所律师")出席了本次会议。根据《中华人民 共和国证券法》(以下简称"《证券法》")、《中华人民共和国公司法》(以 下简称"《公司法》"）、中国证券监督管理委员会《上市公司股东会规则》（以 下简称"《 ...

2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025 年 9 月 15 日 (二)股东大会召开的地点：珠海市情侣南路 1 号仁恒滨海中心 5 座 8 层 证券代码：600568 证券简称：ST 中珠 公告编号：2025-042 号 中珠医疗控股股份有限公司 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 234 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 536,965,541 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 26.9443 | | 份总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由公司董事会召集，由董事长陈旭先生主持，会议采用现场投票和 网络投票相结合的表决方式进行表决。本次会议的召开和表决符合 ...

Group 1 - ST Zhongzhu (600568.SH) released its semi-annual report for 2025 on August 28, 2025 [1] - As of August 27, 2025, six institutional investors disclosed holding ST Zhongzhu A-shares, with a total holding of 770 million shares, accounting for 38.64% of ST Zhongzhu's total share capital [1] - The institutional investors include Shenzhen Landi Technology Development Co., Ltd., Shenzhen Zhongshengyuan Enterprise Management Center (Limited Partnership), Guangzhou Yunying Capital Management Co., Ltd., Shenzhen Kaishengying Technology Co., Ltd., Shenzhen Xinzhenrun Enterprise Management Co., Ltd., and the State-owned Assets Supervision and Administration Commission of Qianjiang City [1]

Core Viewpoint - The company has released its 2025 semi-annual report, which includes details on financial performance, management decisions, and future plans, emphasizing the importance of transparency and compliance with regulatory requirements [5][8][70]. Company Overview - Company Name: Zhongzhu Medical Holdings Co., Ltd. [5] - Stock Code: 600568 [5] - The report is unaudited and aims to provide a comprehensive view of the company's operational results and financial status [2][8]. Financial Data - The report includes key financial data, although specific figures are not detailed in the provided text [4]. - There was no profit distribution or capital reserve transfer during the reporting period [3]. Important Matters - The company has not reported any significant changes in its operational situation during the reporting period [4]. - The board of directors and supervisory board have confirmed the authenticity and completeness of the report [1][5]. Board Meeting Decisions - The board meeting on August 27, 2025, approved the semi-annual report and its summary with unanimous consent [8][69]. - The board also approved a special report on the use of raised funds, which will be disclosed in detail [11][71]. - A proposal to change the accounting firm to Beijing Dehao International Accounting Firm was approved, with audit fees set at 800,000 RMB for financial audit and 300,000 RMB for internal control audit [12][76]. Fund Management - The report outlines the management and usage of raised funds, ensuring compliance with relevant regulations [16][18]. - As of June 30, 2025, the company has utilized 650 million RMB for working capital and various acquisition projects [23]. Upcoming Shareholder Meeting - The company will hold its first extraordinary general meeting of 2025 on September 15, 2025, to discuss the approved proposals [15][41].

Group 1 - Company ST Zhongzhu announced that its 10th Board of Directors held its 9th meeting on August 27, 2025, combining in-person and telecommunication methods [1] - The meeting reviewed the proposal for convening the company's first extraordinary general meeting of shareholders in 2025 [1]

Group 1 - The board of directors of Zhongzhu Medical Holdings Co., Ltd. held its ninth meeting and approved the 2025 semi-annual report and summary with unanimous support [1][2] - The board also approved a special report on the use of raised funds for the first half of 2025, which complies with relevant regulations [2] - A proposal to change the accounting firm was approved, with Beijing Dehao International Accounting Firm being selected for the 2025 financial and internal control audits, with fees set at 800,000 yuan for financial audit and 300,000 yuan for internal control audit [2][3] Group 2 - The board approved the convening of the first extraordinary general meeting of 2025, scheduled for September 15, 2025, at the company's headquarters [3]

Group 1 - The Supervisory Board of Zhongzhu Medical Holdings Co., Ltd. held its fourth meeting and approved the 2025 semi-annual report and summary with unanimous support [1][2] - The meeting also approved a special report on the use of raised funds for the first half of 2025, with all votes in favor [2] - A resolution to change the accounting firm was passed, with the Supervisory Board confirming that the decision followed legal and regulatory requirements and did not harm the interests of shareholders, especially minority shareholders [3] Group 2 - The new accounting firm, Beijing Dehao International Accounting Firm, has qualifications for securities and futures-related business and has extensive auditing experience [3] - The decision to change the accounting firm will be submitted to the company's first extraordinary general meeting of shareholders in 2025 for approval [3]

Meeting Information - The first extraordinary general meeting of shareholders for 2025 will be held on September 15, 2025 [1] - The meeting will utilize a combination of on-site and online voting methods [1][2] - The on-site meeting will take place at 10:00 AM at Renheng Binhai Center, Zhuhai [1] Voting Procedures - Online voting will be conducted through the Shanghai Stock Exchange's system, available from 9:15 AM to 3:00 PM on the day of the meeting [2][4] - Shareholders with multiple accounts can aggregate their voting rights across all accounts [5] - Duplicate voting through different methods will be counted based on the first vote cast [5] Attendance and Registration - Shareholders registered by the close of business on September 8, 2025, are eligible to attend [6] - Registration for attendance requires specific documentation, including identification and stock account information [6] Other Considerations - The company will notify attendees of any significant events that may affect the meeting's proceedings [6] - An authorization letter template is provided for shareholders wishing to delegate their voting rights [7][8]